The Art of Virtualizing Pharma R&D
Journal
Drug Discovery Today
ISSN
1359-6446
Type
journal article
Date Issued
2019
Author(s)
Abstract (De)
Today, virtualizing pharma R&D is increasingly related with data analytics and artificial intelligence (AI), technologies that have been developed by software companies outside the healthcare sector. The process of virtualizing pharma R&D is closely related to the technological advancements that result in the generation of large data sets ranging from genomics, proteomics, metabolomics, medical imaging, IoT wearables and large clinical trials, making it necessary for pharma companies to find new ways to store and ultimately analyze information. As a consequence, pharma companies are experimenting with AI in R&D ranging from in-silico drug design to clinical trail participants identification or dosage error reduction
Language
English
HSG Classification
contribution to scientific community
HSG Profile Area
SoM - Business Innovation
Refereed
Yes
Publisher
Elsevier Science
Publisher place
Amsterdam
Volume
24
Number
11
Start page
2105
End page
2107
Pages
3
Subject(s)
Division(s)
Eprints ID
257528